Agenus (AGEN) researches and develops innovative immunological agents and combination therapies designed to treat various forms of cancer. By focusing on immuno-oncology breakthroughs, the company seeks to activate patient immune systems against tumors through advanced antibody discovery and cellular therapy platforms.